{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:27:34Z","timestamp":1792132054543,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaad.2018.08.052","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T12:38:04Z","timestamp":1537274284000},"page":"670-678.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease"],"prefix":"10.1016","volume":"80","author":[{"given":"Yoshiko","family":"Mizukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Hirahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.08.052_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/17425255.2017.1297422","article-title":"Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"13","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jaad.2018.08.052_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8421-3","article-title":"Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review","volume":"49","author":"Shiohara","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2018.08.052_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib6","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2340\/00015555-2149","article-title":"Involvement of human herpesvirus 6 infection in renal dysfunction associated with DIHS\/DRESS","volume":"96","author":"Miyashita","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.08.052_bib8","first-page":"842","article-title":"Severe agranulocytosis in two patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"96","author":"Kato","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.08.052_bib9","first-page":"124","article-title":"Multiple cavities with halo sign in a case of invasive pulmonary aspergillosis during therapy for drug-induced hypersensitivity syndrome","volume":"21","author":"Ikari","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jaad.2018.08.052_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1346-8138.2005.tb00762.x","article-title":"Drug-induced hypersensitivity syndrome due to mexiletine-associated with human herpes virus 6 and cytomegalovirus reactivation","volume":"32","author":"Sekiguchi","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/00015555-1863","article-title":"DIHS\/DRESS with remarkable eosinophilic pneumonia caused by zonisamide","volume":"95","author":"Shibuya","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.08.052_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2169\/internalmedicine.40.331","article-title":"Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia","volume":"40","author":"Arakawa","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2018.08.052_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4103\/0019-5154.91850","article-title":"DRESS syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum","volume":"56","author":"Giri","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdcr.2015.04.017","article-title":"Detection of cytomegalovirus in the gastric ulcer of a patient with drug-induced hypersensitivity syndrome","volume":"1","author":"Kagoyama","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2018.08.052_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","article-title":"Therapeutic management of DRESS: a retrospective study of 38 cases","volume":"72","author":"Funck-Brentano","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitiviity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.08.052_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2018.08.052_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1684\/ejd.2011.1550","article-title":"Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS)","volume":"21","author":"Wei","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B* 58:01 allele and renal impairment of allopurinol-induced cutaneous adverse reaction","volume":"136","author":"Ng","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.08.052_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/rheumatology\/ken231","article-title":"Clinical characteristics of cytomegalovirus infection in rheumatic disease: multicentre survey in a large patient population","volume":"47","author":"Takizawa","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaad.2018.08.052_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2279-042X.176554","article-title":"The risk factor for cytomegalovirus reactivation following stem cell transplantation","volume":"5","author":"Valadkhani","year":"2016","journal-title":"J Res Pharm Pract"},{"key":"10.1016\/j.jaad.2018.08.052_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.24078","article-title":"Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?","volume":"21","author":"Bruminhent","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2018.08.052_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definition of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2018.08.052_bib28","first-page":"858","article-title":"Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection","volume":"20","author":"Ormeci","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jaad.2018.08.052_bib29","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/j.1572-0241.2006.00869.x","article-title":"Cytomegalovirus colitis complicating inflammatory bowel disease","volume":"101","author":"Kandiel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2018.08.052_bib30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1128\/JCM.42.4.1498-1504.2004","article-title":"Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection","volume":"42","author":"Kalpoe","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2018.08.052_bib31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.transproceed.2011.12.025","article-title":"Post-renal transplant cytomegalovirus infection: study of risk factors","volume":"44","author":"Kute","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2018.08.052_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","article-title":"Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy","volume":"59","author":"Shiohara","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaad.2018.08.052_bib33","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.4049\/jimmunol.173.12.7481","article-title":"Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection","volume":"173","author":"Khan","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2018.08.052_bib34","first-page":"60","article-title":"Herpesvirus infection in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infection","volume":"10","author":"Razonable","year":"2003","journal-title":"Herpes"},{"key":"10.1016\/j.jaad.2018.08.052_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/tid.12579","article-title":"Viral load and ganciclovir (GCV) consentratation in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis\/myelitis following umbilical cord blood transplantation","volume":"18","author":"Morita","year":"2016","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218325854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:33Z","timestamp":1759272573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218325854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0190962218325854"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}